14 Jan 2025

Real-world evidence (RWE) and Clinical Trials: Complementary roles in evidence- based research for all patients

2025-01-14T10:51:47+01:00January 14, 2025|All, HEOR Insights|

Certain patient groups may be underrepresented or excluded from RCTs due to eligibility criteria, logistical barriers, ethical concerns or other reasons.

Examples of these potential groups are females, pregnant or breastfeeding females, older adults due to age or comorbidities, children, people […]

3 Dec 2024

MASLD/MASH: Clinical and Economic Findings from 40-year Follow-Up Data

2024-12-04T16:34:27+01:00December 3, 2024|All, Other|

πŒπ€π’π‹πƒ/πŒπ€π’π‡: 𝐂π₯𝐒𝐧𝐒𝐜𝐚π₯ 𝐚𝐧𝐝 π„πœπ¨π§π¨π¦π’πœ 𝐅𝐒𝐧𝐝𝐒𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 40-𝐲𝐞𝐚𝐫 𝐅𝐨π₯π₯𝐨𝐰-𝐔𝐩 πƒπšπ­πš
On Tuesday December 10th, Quantify’s Emilie Toresson Grip is one of three speakers at ISPOR’s webinar on MASLD/ MASH following their BRIDGE-MASH study.

Moderated by Riku Ota, Global Payer Evidence Lead at […]

Go to Top